The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 13, 2016

Filed:

Sep. 13, 2012
Applicants:

Satomi Onoue, Shizuoka, JP;

Shizuo Yamada, Shizuoka, JP;

Inventors:

Satomi Onoue, Shizuoka, JP;

Shizuo Yamada, Shizuoka, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 47/26 (2006.01); A61K 31/4418 (2006.01); A61K 9/00 (2006.01); A61M 15/00 (2006.01); A61M 11/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/14 (2013.01); A61K 9/0075 (2013.01); A61K 9/145 (2013.01); A61K 9/146 (2013.01); A61K 31/4418 (2013.01); A61K 47/26 (2013.01); A61M 11/002 (2014.02); A61M 15/00 (2013.01); A61M 2202/064 (2013.01);
Abstract

The present invention relates to a powder formulation which reduces side effect risk of a medicine having a side effect of drug-induced photodermatosis and increases therapeutic effect, and relates to the method for producing the same. Said powder formulation makes inhalation therapy possible by carrying out aerosolization easily, and since pharmacological effect in lung local part is increased, it is possible to decrease the dose. Skin transmigration of said medicine is controlled by a lung specific delivery technology, and photodermatosis which is a side effect can be controlled.


Find Patent Forward Citations

Loading…